Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl
- PMID: 40244334
- DOI: 10.1007/s00213-025-06790-2
Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl
Abstract
Rational: Furanylfentanyl and tetrahydrofuranylfentanyl (THF-F) have been emerging in numerous intoxication and overdose cases in recent years. However, there remains a data deficiency regarding the abuse potential of these novel fentanyl analogs.
Objectives: This study was designed to systematically assess the abuse potential of furanylfentanyl and THF-F.
Methods: In this study, we evaluated the abuse potential of furanylfentanyl and THF-F via the conditioned place preference (CPP), drug self-administration, drug discrimination, and naloxone-precipitated withdrawal experiments with fentanyl as a reference.
Results: Results from CPP experiments indicated that furanylfentanyl and THF-F could induce CPP at minimum doses of 0.1 mg/kg and 3 mg/kg, respectively. These doses were 1 time and 30 times that of fentanyl (0.1 mg/kg). Furanylfentanyl elicited stable self-administration responses at 2.5 µg/kg/infusion, whereas THF-F did so at 50 µg/kg/infusion. In the drug-substitution test, furanylfentanyl and THF-F induced the maximum number of infusions at 1.10 µg/kg and 12.5 µg/kg, respectively, which were 1 time and 10 times that of fentanyl (1.21 µg/kg). In drug discrimination tests, all three substances were fully substituted for the discriminative-stimulus effects of heroin dose-dependently. The substitution potency of furanylfentanyl (ED50 = 2.68 µg/kg) was similar to that of fentanyl (ED50 = 2.66 µg/kg), while THF-F (ED50 = 36.32 µg/kg) was 14-fold less potent than fentanyl. Repeated administration of furanylfentanyl and THF-F produced naloxone-precipitated withdrawal symptoms. Thus, furanylfentanyl exhibited comparable potency to fentanyl in terms of rewarding, reinforcing, and subjective effects, while THF-F had reduced potency in these effects. Both of them had physical dependence.
Conclusions: Taken together, our study presented new evidence indicating that furanylfentanyl and THF-F exhibit significant abuse potential in rodent models, which provides experimental data for the control. Furthermore, our study offered valuable information for future studies into the addictive properties of structurally modified fentanyl analogs.
Keywords: Conditioned place preference; Drug discrimination; Fentanyl; Furanylfentanyl; Naloxone-precipitated withdrawal; Self-administration; Tetrahydrofuranylfentanyl.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: All procedures followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Conflict of interest: The authors declare no conflict of interest related to this work.
Similar articles
-
Assessment of abuse potential of carfentanil.Addict Biol. 2023 Feb;28(2):e13265. doi: 10.1111/adb.13265. Addict Biol. 2023. PMID: 36692872
-
Isobutyryl-carfentanyl has strong acute toxicity and analgesic effects with high addiction potential.Psychopharmacology (Berl). 2025 Jan;242(1):205-214. doi: 10.1007/s00213-024-06664-z. Epub 2024 Aug 7. Psychopharmacology (Berl). 2025. PMID: 39110217
-
Highly potent fentanyl analogs: apnea from exposure to small quantities of ß-hydroxyfentanyl and furanylfentanyl.Clin Toxicol (Phila). 2019 Sep;57(9):813-815. doi: 10.1080/15563650.2018.1558233. Epub 2019 Mar 19. Clin Toxicol (Phila). 2019. PMID: 30888883
-
An Expanding World of Novel Psychoactive Substances: Opioids.Front Psychiatry. 2017 Jun 30;8:110. doi: 10.3389/fpsyt.2017.00110. eCollection 2017. Front Psychiatry. 2017. PMID: 28713291 Free PMC article. Review.
-
Emerging Synthetic Fentanyl Analogs.Acad Forensic Pathol. 2017 Mar;7(1):36-40. doi: 10.23907/2017.004. Epub 2017 Mar 1. Acad Forensic Pathol. 2017. PMID: 31239954 Free PMC article. Review.
References
-
- Anand JP, Boyer BT, Mosberg HI et al (2016) The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice. Psychopharmacology 233:2479–2487. https://doi.org/10.1007/s00213-016-4296-8 - DOI
-
- Åstrand A, Vikingsson S, Jakobsen I et al (2020) Activation of the µ-opioid receptor by alicyclic fentanyls: changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure. Drug Test Anal. https://doi.org/10.1002/dta.2906 - DOI
-
- Barbosa LM, Santos JM, de Morais DR et al (2019) Fast UHPLC-MS/MS method for analysis of furanylfentanyl in different seized blotter papers. Drug Test Anal 11:178–183. https://doi.org/10.1002/dta.2472 - DOI
-
- Belin-Rauscent A, Fouyssac M, Bonci A et al (2016) How preclinical models evolved to resemble the diagnostic criteria of drug addiction. Biol Psychiatry 79:39–46. https://doi.org/10.1016/j.biopsych.2015.01.004 - DOI
-
- Bilel S, Azevedo Neto J, Arfè R et al (2022) In vitro and in vivo pharmaco-dynamic study of the novel Fentanyl derivatives: Acrylfentanyl, Ocfentanyl and furanylfentanyl. Neuropharmacology 209:109020. https://doi.org/10.1016/j.neuropharm.2022.109020 - DOI
MeSH terms
Substances
Grants and funding
- 82130056/National Natural Science Foundation of China
- 2022KY342/Medical Science and Technology Project of Zhejiang Provience
- RS2024H006/Research Program on the Guiding Principles for the Formulation and Adjustment of the Control Level for Narcotic and Psychotropic Substances
- 2024S025/Ningbo Public Welfare Research Project
LinkOut - more resources
Full Text Sources